THE CHARACTERISTICS OF THE MICROSOMAL HYDROXYLATION OF TOLBUTAMIDE

被引:10
作者
BELANGER, PM
STHILAIRE, S
机构
[1] Ecole de pharmacie, Universite Laval, Ste-Foy, Que.
关键词
TOLBUTAMIDE METABOLISM; TOLBUTAMIDE HYDROXYLATION; MICROSOMAL HYDROXYLATION; MICROSOMAL METABOLISM OF TOLBUTAMIDE; HEPATIC METABOLISM OF TOLBUTAMIDE; ANAU COMPLEX; DARRAN COMPLEX; NEW STRATIGRAPHIC NAMES;
D O I
10.1139/y91-061
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The in vitro metabolism of tolbutamide to the hydroxymethyl derivative was studied using hepatic microsomal homogenates. The hydroxymethyl metabolite was quantitated by HPLC. The hepatic microsomal hydroxylase was completely inhibited by carbon monoxide and was NADPH dependent. Metyrapone, alpha-naphthoflavone, phenelzine, mercuric chloride, and nitrogen significantly inhibited the reaction indicating the involvement of the cytochrome P-450 monooxygenase. Species variation showed that the order of hepatic microsomal activity was rat > rabbit >> guinea pig >> mouse and hamster. The reaction increased with time up to 40 min and followed Michaelis-Menten kinetics in rat liver microsomes with apparent K(m) and V(max) values of 224.4-mu-M and 359.9 pmol.mg-1.min-1, respectively. The reaction was induced by phenobarbital but was depressed after pretreatment with 3-methylcholanthrene and isosafrole. However, expression of the hydroxylase activity per nanomoles of cytochrome P-450 showed that the activity was much higher in liver microsomes of isosafrole pretreated rats. These results indicate the involvement of different isozymes of cytochrome P-450 in the microsomal hydroxylation of tolbutamide.
引用
收藏
页码:400 / 405
页数:6
相关论文
共 37 条
[1]   INVITRO INHIBITION STUDIES OF TOLBUTAMIDE HYDROXYLASE-ACTIVITY OF HUMAN-LIVER MICROSOMES BY AZOLES, SULFONAMIDES AND QUINOLINES [J].
BACK, DJ ;
TJIA, JF ;
KARBWANG, J ;
COLBERT, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 26 (01) :23-29
[2]   INHIBITORY EFFECT OF PHENELZINE ON OXIDATIVE MICROSOMAL-ENZYME SYSTEMS OF RAT-LIVER [J].
BELANGER, PM ;
ATITSEGBEASSOR, A .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1983, 61 (05) :524-529
[3]  
BELANGER PM, 1977, CAN J PHARM SCI, V12, P99
[4]   THE INHIBITORY EFFECT OF MONOAMINE-OXIDASE INHIBITORS ON HEPATIC MICROSOMAL-ENZYME SYSTEMS OF RAT-LIVER [J].
BELANGER, PM ;
ATITSEGBEASSOR, A .
PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1981, 13 (09) :819-828
[5]   INVITRO STUDIES OF INDUCTION AND INHIBITION OF DRUG OXIDATION IN MAN [J].
BOOBIS, AR ;
MURRAY, S ;
SEDDON, CE ;
DAVIES, DS .
PHARMACOLOGY & THERAPEUTICS, 1987, 33 (01) :101-108
[6]   AMINO-TERMINAL AND CARBOXY-TERMINAL SEQUENCE OF HEPATIC-MICROSOMAL CYTOCHROME-P-450D, A UNIQUE HEMOPROTEIN FROM RATS TREATED WITH ISOSAFROLE [J].
BOTELHO, LH ;
RYAN, DE ;
YUAN, PM ;
KUTNY, R ;
SHIVELY, JE ;
LEVIN, W .
BIOCHEMISTRY, 1982, 21 (06) :1152-1155
[8]   STUDIES ON INTERACTION OF SAFROLE WITH RAT HEPATIC MICROSOMES [J].
ELCOMBE, CR ;
BRIDGES, JW ;
GRAY, TJB ;
NIMMOSMITH, RH ;
NETTER, KJ .
BIOCHEMICAL PHARMACOLOGY, 1975, 24 (15) :1427-1433
[9]  
FISHER GJ, 1981, J BIOL CHEM, V256, P4388
[10]   INHIBITION OF HEPATIC OXIDATIVE XENOBIOTIC METABOLISM BY PIPERONYL BUTOXIDE [J].
FRANKLIN, MR .
BIOCHEMICAL PHARMACOLOGY, 1972, 21 (24) :3287-+